Polydopamine-based coordination nanocomplex for T1/T2 dual mode magnetic resonance imaging-guided chemo-photothermal synergistic therapy

Biomaterials

Volumn 77, Issue , 2016, Pages 198-206

  Chen, Yan ^a,b   Ai, Kelong ^a   Liu, Jianhua ^c   Ren, Xiaoyan ^a   Jiang, Chunhuan ^a   Lu, Lehui ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Chemo photothermal synergistic therapy; Coordination polymer; Magnetic resonance imaging; Polydopamine; T1 T2 dual mode

Indexed keywords

BIODEGRADABLE POLYMERS; CHEMOTHERAPY; COORDINATION REACTIONS; EFFICIENCY; MAGNETISM; METAL IONS; RESONANCE; SYNTHESIS (CHEMICAL);

BINDING ABILITIES; COORDINATION POLYMERS; DUAL MODES; PHOTO-THERMAL; PHOTOTHERMAL CONVERSION EFFICIENCIES; POLYDOPAMINE; SYNTHESIS STRATEGY; THERANOSTIC AGENTS;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; COORDINATION POLYMER; DRUG CARRIER; IRON; NANOSPHERE; POLYDOPAMINE; POLYMER; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; CHLORIDE; COORDINATION COMPOUND; DOXORUBICIN; FERRIC CHLORIDE; FERRIC ION; GLASS FIBER; INDOLE DERIVATIVE; NANOCOMPOSITE; TRICARBOXYLIC ACID; TRIMESIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HELA CELL LINE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOTHERAPY; PRIORITY JOURNAL; SURVIVAL RATE; SYNTHESIS; ANIMAL; CHEMISTRY; DIATHERMY; DIODE LASER; DRUG SCREENING; LIVER NEOPLASMS, EXPERIMENTAL; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; POLYMERIZATION; PROCEDURES; RADIATION RESPONSE; RANDOMIZATION; THERANOSTIC NANOMEDICINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHLORIDES; COMBINED MODALITY THERAPY; CONTRAST MEDIA; COORDINATION COMPLEXES; DIATHERMY; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; FERRIC COMPOUNDS; HELA CELLS; HUMANS; INDOLES; LASERS, SEMICONDUCTOR; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; NANOCOMPOSITES; OPTICAL FIBERS; POLYMERIZATION; POLYMERS; RANDOM ALLOCATION; THERANOSTIC NANOMEDICINE; TRICARBOXYLIC ACIDS;

EID: 84949200900     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.11.010     Document Type: Article

References (42)

1. Stewart B.W., Wild C.P. World Cancer Report 2014 2014, International Agency for Research on Cancer, Lyon, France.
2. Xie J., Lee S., Chen X. Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev. 2010, 62:1064-1079.
3. Lammers T., Aime S., Hennink W.E., Storm G., Kiessling F. Theranostic nanomedicine. Acc. Chem. Res. 2011, 44:1029-1038.
4. Jokerst J.V., Gambhir S.S. Molecular imaging with theranostic nanoparticles. Acc. Chem. Res. 2011, 44:1050-1060.
5. Ma X., Zhao Y., Liang X.-J. Theranostic nanoparticles engineered for clinic and pharmaceutics. Acc. Chem. Res. 2011, 44:1114-1122.
6. Chen X., Gambhir S.S., Cheon J. Theranostic nanomedicine. Acc. Chem. Res. 2011, 44:841.
7. Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv. Mater. 2009, 21:2133-2148.
8. Chen Y., Ai K., Liu J., Sun G., Yin Q., Lu L. Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging. Biomaterials 2015, 60:111-120.
9. Liu Y., Ai K., Yuan Q., Lu L. Fluorescence-enhanced gadolinium-doped zinc oxide quantum dots for magnetic resonance and fluorescence imaging. Biomaterials 2011, 32:1185-1192.
10. 1-xO colloidal solid solution as a dual magnetic-resonance-contrast agent. Small 2009, 5:571-573.
11. Wang X., Niu D., Wu Q., Bao S., Su T., Liu X., et al. Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents. Biomaterials 2015, 53:349-357.
12. Seo W.S., Lee J.H., Sun X., Suzuki Y., Mann D., Liu Z., et al. FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents. Nat. Mater. 2006, 5:971-976.
13. Li Z., Yi P.W., Sun Q., Lei H., Li Zhao H., Zhu Z.H., et al. Ultrasmall water-soluble and biocompatible magnetic iron oxide nanoparticles as positive and negative dual contrast agents. Adv. Funct. Mater. 2012, 22:2387-2393.
14. 2-weighted magnetic resonance imaging. ACS Nano 2014, 8:9884-9896.
15. 2 dual-modal contrast agent. Adv. Mater. 2012, 24:6223-6228.
16. Choi J.-S., Lee J.-H., Shin T.-H., Song H.-T., Kim E.Y., Cheon J. Self-confirming "AND" logic nanoparticles for fault-free MRI. J. Am. Chem. Soc. 2010, 132:11015-11017.
17. Zhu Z., Wang X., Li T., Aime S., Sadler P.J., Guo Z. Platinum(II)-gadolinium(III) complexes as potential single-molecular theranostic agents for cancer treatment. Angew. Chem. Int. Ed. 2014, 53:13225-13228.
18. 4 nanoroses with five unique functions for cancer cell targeting, imaging, and therapy. Adv. Funct. Mater. 2014, 24:1772-1780.
19. Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 2010, 7:653-664.
20. Zhang Z., Wang J., Chen C. Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging. Adv. Mater. 2013, 25:3869-3880.
21. Wang Y., Wang K., Zhao J., Liu X., Bu J., Yan X., et al. Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma. J. Am. Chem. Soc. 2013, 135:4799-4804.
22. 2S nanocrystals as trimodal imaging and synergistic chemo-photothermal therapy agents. Nanoscale 2015, 7:8378-8388.
23. Yang K., Xu H., Cheng L., Sun C., Wang J., Liu Z. In vitro and in vivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles. Adv. Mater. 2012, 24:5586-5592.
24. Liu Y., Ai K., Liu J., Deng M., He Y., Lu L. Dopamine-melanin colloidal nanospheres: an efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy. Adv. Mater. 2013, 25:1353-1359.
25. Sherlock S.P., Tabakman S.M., Xie L., Dai H. Photothermally enhanced drug delivery by ultrasmall multifunctional FeCo/graphitic shell nanocrystals. ACS Nano 2011, 5:1505-1512.
26. Fan Q., Cheng K., Hu X., Ma X., Zhang R., Yang M., et al. Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging. J. Am. Chem. Soc. 2014, 136:15185-15194.
27. 1-weighted magnetic resonance imaging. Biomacromolecules 2013, 14:3491-3497.
28. He C., Liu D., Lin W. Self-assembled nanoscale coordination polymers carrying siRNAs and cisplatin for effective treatment of resistant ovarian cancer. Biomaterials 2015, 36:124-133.
29. Liu F., He X., Chen H., Zhang J., Zhang H., Wang Z. Gram-scale synthesis of coordination polymer nanodots with renal clearance properties for cancer theranostic applications. Nat. Commun. 2015, 6.
30. Ju K.-Y., Lee S., Pyo J., Choo J., Lee J.-K. Bio-inspired development of a dual-mode nanoprobe for MRI and Raman imaging. Small 2015, 11:84-89.
31. Horcajada P., Chalati T., Serre C., Gillet B., Sebrie C., Baati T., et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat. Mater. 2010, 9:172-178.
32. Liu Y., Ai K., Lu L. Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields. Chem. Rev. 2014, 114:5057-5115.
33. 5 nanoparticles: novel binary contrast agent for high-resolution in vivo X-ray computed tomography angiography. Adv. Healthc. Mater. 2012, 1:461-466.
34. Liu Y., Ai K., Liu J., Yuan Q., He Y., Lu L. A High-performance ytterbium-based nanoparticulate contrast agent for in vivo X-ray computed tomography imaging. Angew. Chem. Int. Ed. 2012, 51:1437-1442.
35. 1 contrast agents for efficient tumor imaging. ACS Nano 2013, 7:3287-3296.
36. 1 magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 2011, 133:12624-12631.
37. 2 core-shell nanocubes: novel bimodal contrast agents for MRI and optical imaging. Sci. Rep. 2013, 3.
38. 1 contrast. Nat. Nano 2010, 5:815-821.
39. Chen Y., Ai K., Liu Y., Lu L. Tailor-made charge-conversional nanocomposite for pH-responsive drug delivery and cell imaging. ACS Appl. Mater. Interfaces 2014, 6:655-663.
40. Peng F., Su Y., Wei X., Lu Y., Zhou Y., Zhong Y., et al. Silicon-nanowire-based nanocarriers with ultrahigh drug-loading capacity for in vitro and in vivo cancer therapy. Angew. Chem. Int. Ed. 2013, 52:1457-1461.
41. Chemicalland 21 Trimesic Acid 2008, Online, Available from URL:. http://www.chemicalland21.com/specialtychem/perchem/TRIMESIC%20ACID.htm.
42. 1 MRI contrast agent. J. Am. Chem. Soc. 2013, 135:18621-18628.